Hsp90 Inhibitors and the Reduction of Anti-Cancer Drug Resistance by Non-Genetic and Genetic Mechanisms

In this review, we focus on how inhibitors of Hsp90 can help prevent the resistance to anti-cancer drugs by synergistically increasing their cancer killing abilities and thereby allowing them to function at much lower concentrations than normally used. Hsp90 helps to fold numerous client proteins, s...

Full description

Bibliographic Details
Main Authors: Douglas M. Ruden, Xiangyi Lu, Luan Wang
Format: Article
Language:English
Published: MDPI AG 2012-08-01
Series:Pharmaceuticals
Subjects:
Online Access:http://www.mdpi.com/1424-8247/5/9/890